Retreating patients with hepatitis C: Telaprevir boosts cure rate

Adding the investigational drug telaprevir to standard treatment for hepatitis C infection cures about half the patients willing to give therapy a second try. That compares to a cure rate of just 14 percent among those who were retreated with the standard regimen, according to new research.

Read the whole article on Science Daily

More from Science Daily